tradingkey.logo
搜尋

Oncology Institute Inc

TOI
添加自選
4.860USD
-0.210-4.14%
收盤 07-31 16:00美東報價延遲15分鐘
485.87M總市值
虧損本益比TTM

關於 Oncology Institute Inc 公司

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Oncology Institute Inc簡介

公司代碼TOI
公司名稱Oncology Institute Inc
上市日期Mar 13, 2020
CEOVirnich (Daniel)
員工數量825
證券類型Ordinary Share
年結日Mar 13
公司地址18000 Studebaker Rd
城市CERRITOS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編90703
電話15627353226
網址https://theoncologyinstitute.com/
公司代碼TOI
上市日期Mar 13, 2020
CEOVirnich (Daniel)

Oncology Institute Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

常見問題

Oncology Institute Inc的前五大股東是誰?

Oncology Institute Inc的前五大股東如下:Dr. Daniel Virnich, M.D.

有多少機構持有Oncology Institute Inc(TOI)的股份?

截至2026Q1,共有204家機構持有Oncology Institute Inc的股份,合計持有的股份價值約為47.47M,占公司總股份的47.57% 。與2025Q4相比,機構持股有所增加,增幅為-10136464.00。

哪個業務部門對Oncology Institute Inc的收入貢獻最大?

在2026Q1,Dispensary revenue業務部門對Oncology Institute Inc的收入貢獻最大,創收269.18M,占總收入的53.54% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有